Address
Aisling Capital
888 Seventh Avenue
30th Floor
New York, NY 10106
United States
Phone
Email
Website
Recent investment activity
KANDO id: 1260
Corporate information
Registration country
Funds managed
| Fund | Type | Vintage | Currency | Committed capital | IRR | x |
|---|---|---|---|---|---|---|
| Aisling Capital IV LP | 2016 | USD | 400,000,000 | |||
| Aisling Capital III LP | 2008 | USD | 650,000,000 | 26.40 % | 2.20 x | |
| Aisling Capital II LP | 2005 | USD | 550,000,000 | 0.50 % | 1.00 x | |
| Aisling Capital I LP | 2002 | 20.00 % |
Funding rounds
Actual initial investment stage
Series A (1)
Investment activity status
Active investor
Selected investments
Displaying 1 - 25 of 30| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Advion BioSciences Inc (Advion Inc) | Medical device company innovating purpose-built products that improve workflows for the life science industry. | N/A | |||
|
|
Allos Therapeutics Inc | N/A | ||||
|
|
Aragon Pharmaceuticals Inc | Aragon Pharmaceuticals is a privately held, small-molecule drug discovery company. | N/A | |||
|
Auxilium Pharmaceuticals Inc | N/A | ||||
|
|
Axcan Pharma Inc | Specialty pharmaceutical company focused on gastroenterology. | N/A | |||
|
|
Cempra Inc | Developer of a drugs for difficult-to-treat and drug-resistant bacterial infections. | N/A | |||
|
|
Durata Therapeutics Inc | Durata Therapeutics is a clinical development stage biopharmaceutical company. | N/A | |||
|
|
Esperion Therapeutics Inc | N/A | ||||
|
|
MAP Pharmaceuticals Inc | Proprietary inhalation technologies to enhance the therapeutic benefits and commercial attractiveness of proven drugs. | N/A | |||
|
|
Miramar Labs Inc | Developing devices for aesthetic indications | N/A | |||
|
|
Pernix Therapeutics Holdings Inc | Pernix Therapeutics Holdings, Inc. is a specialty pharmaceutical company. | N/A | |||
|
Replidyne Inc | Biopharmaceutical company, engages in discovering, developing, in-licensing, and commercializing anti-infective products. | N/A | |||
|
|
Roka Bioscience Inc | Series D | ||||
|
|
Scerene Healthcare Inc | Emerging consumer products company. | N/A | |||
|
|
T2 Biosystems Inc | Rapid, decentralized molecular diagnostic tests and systems that detect fungal and bacterial infections, as well as complementary immunodiagnostics. | N/A | |||
|
|
T2 Biosystems Inc | Rapid, decentralized molecular diagnostic tests and systems that detect fungal and bacterial infections, as well as complementary immunodiagnostics. | N/A | |||
|
|
Topaz Pharmaceuticals Inc | A later-stage pediatric specialty pharmaceutical company developing a topical prescription product for the treatment of head lice. | N/A | |||
|
|
TransEnterix Inc | Medical device company focused on innovative techniques and tools for minimally invasive surgery. | N/A | |||
|
|
TRIA Beauty Inc | Venture | ||||
|
|
TRIA Beauty Inc | Series E | ||||
|
|
ViewRay Inc [] | A medical device company, develops advanced radiation therapy solutions for the treatment of cancer. | N/A | |||
|
|
Xanodyne Pharmaceuticals Inc | Specialty pharmaceuticals for pain and women's health | Series D | |||
|
Zeltiq Aesthetics Inc | N/A | ||||
|
Ajax Health LLC | Series C | ||||
|
|
Ajax Health LLC | Series B |